Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study evaluates the ability of tamoxifen to improve frequent or prolonged bleeding in new users of the 52mg levonorgestrel-releasing intrauterine device (IUD). Half of participants will receive a course of tamoxifen three weeks after insertion of the IUD, while the other half of participants will receive a course of placebo.
Epistemonikos ID: bb44ef441971815b89fd1fc476dbdc1f74dfe585
First added on: May 17, 2024